KRAS and cancer: Glutamine addiction extends from the context of MYC, and mutations in KRAS —a key gene related to the stability and activity of c-MYC protein— in cancer cells similarly cause dependence on exogenous glutamine for cellular growth and proliferation, as does MYC amplification (162, 179, 180).